CY1118117T1 - Νεα αμινο-πυρρολινικα παραγωγα και η χρηση τους στην προληψη ή και τη θεραπεια του μεταβολικου συνδρομου - Google Patents
Νεα αμινο-πυρρολινικα παραγωγα και η χρηση τους στην προληψη ή και τη θεραπεια του μεταβολικου συνδρομουInfo
- Publication number
- CY1118117T1 CY1118117T1 CY20161100829T CY161100829T CY1118117T1 CY 1118117 T1 CY1118117 T1 CY 1118117T1 CY 20161100829 T CY20161100829 T CY 20161100829T CY 161100829 T CY161100829 T CY 161100829T CY 1118117 T1 CY1118117 T1 CY 1118117T1
- Authority
- CY
- Cyprus
- Prior art keywords
- prevention
- treatment
- metabolic syndrome
- pyrroline
- products
- Prior art date
Links
- 208000001145 Metabolic Syndrome Diseases 0.000 title abstract 2
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- NPLSMQWSKZXZPD-UHFFFAOYSA-N 2,3-dihydropyrrol-1-amine Chemical compound NN1CCC=C1 NPLSMQWSKZXZPD-UHFFFAOYSA-N 0.000 title 1
- SBMSLRMNBSMKQC-UHFFFAOYSA-N pyrrolidin-1-amine Chemical class NN1CCCC1 SBMSLRMNBSMKQC-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Νέα αμινο-πυρρολινικά παράγωγα, τα φαρμακολογικά αποδεκτά άλατα τους και η χρήση τους στην πρόληψη ή και τη θεραπεία του μεταβολικού συνδρόμου.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1153375A FR2974364B1 (fr) | 2011-04-19 | 2011-04-19 | Nouveaux derives amino-pyrroliniques, leur utilisation dans la prevention et/ou le traitement du syndrome metabolique |
| FR1251302 | 2012-02-13 | ||
| PCT/FR2012/050835 WO2012143660A1 (fr) | 2011-04-19 | 2012-04-17 | Nouveaux derives amino-pyrroliniques, leur utilisation dans la prevention et/ou le traitement du syndrome metabolique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1118117T1 true CY1118117T1 (el) | 2017-06-28 |
Family
ID=46146922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20161100829T CY1118117T1 (el) | 2011-04-19 | 2016-08-22 | Νεα αμινο-πυρρολινικα παραγωγα και η χρηση τους στην προληψη ή και τη θεραπεια του μεταβολικου συνδρομου |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9303019B2 (el) |
| EP (1) | EP2699545B1 (el) |
| JP (1) | JP5986625B2 (el) |
| CN (1) | CN103619814B (el) |
| CA (1) | CA2833339C (el) |
| CY (1) | CY1118117T1 (el) |
| DK (1) | DK2699545T3 (el) |
| ES (1) | ES2588059T3 (el) |
| HR (1) | HRP20161024T1 (el) |
| HU (1) | HUE030432T2 (el) |
| LT (1) | LT2699545T (el) |
| PL (1) | PL2699545T3 (el) |
| PT (1) | PT2699545T (el) |
| RS (1) | RS55061B1 (el) |
| SI (1) | SI2699545T1 (el) |
| SM (1) | SMT201600284B (el) |
| WO (1) | WO2012143660A1 (el) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112015014191B1 (pt) * | 2012-12-19 | 2019-08-27 | Bayer Cropscience Ag | indanil carboxamidas difluorometilnicotínicas |
| WO2023084054A1 (en) | 2021-11-12 | 2023-05-19 | 3Z Ehf | Treatment of adhd using selective binders of the 11-imidazoline receptor |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670859A1 (de) * | 1967-04-24 | 1971-03-11 | Bayer Ag | Verfahren zur Herstellung von 2-Phenyl-imino-1-azacycloalkanen |
| US3679692A (en) * | 1969-10-01 | 1972-07-25 | Mead Johnson & Co | Iminomethylindolines |
| US4533739A (en) * | 1982-10-12 | 1985-08-06 | G. D. Searle & Co. | 2-[(Aminophenyl and amidophenyl)amino]-1-azacycloalkanes having antidiarrheal activity |
| US4579951A (en) | 1984-03-19 | 1986-04-01 | G. D. Searle & Co. | Substituted (azacycloalk-2-yl)iminophenols and esters thereof |
| US9040532B2 (en) | 2009-10-06 | 2015-05-26 | Allergan, Inc. | Alpha adrenergic receptor modulators |
| BR112012011347A2 (pt) * | 2009-10-21 | 2019-09-24 | Allergan Inc | "moduladores de receptor alfa adrenérgico." |
-
2012
- 2012-04-17 EP EP12722423.6A patent/EP2699545B1/fr active Active
- 2012-04-17 ES ES12722423.6T patent/ES2588059T3/es active Active
- 2012-04-17 US US14/112,631 patent/US9303019B2/en not_active Expired - Fee Related
- 2012-04-17 SI SI201230681A patent/SI2699545T1/sl unknown
- 2012-04-17 PL PL12722423T patent/PL2699545T3/pl unknown
- 2012-04-17 WO PCT/FR2012/050835 patent/WO2012143660A1/fr active Application Filing
- 2012-04-17 LT LTEP12722423.6T patent/LT2699545T/lt unknown
- 2012-04-17 DK DK12722423.6T patent/DK2699545T3/en active
- 2012-04-17 HR HRP20161024TT patent/HRP20161024T1/hr unknown
- 2012-04-17 CN CN201280019520.6A patent/CN103619814B/zh not_active Expired - Fee Related
- 2012-04-17 RS RS20160689A patent/RS55061B1/sr unknown
- 2012-04-17 JP JP2014505700A patent/JP5986625B2/ja not_active Expired - Fee Related
- 2012-04-17 CA CA2833339A patent/CA2833339C/fr not_active Expired - Fee Related
- 2012-04-17 PT PT127224236T patent/PT2699545T/pt unknown
- 2012-04-17 HU HUE12722423A patent/HUE030432T2/en unknown
-
2016
- 2016-08-22 CY CY20161100829T patent/CY1118117T1/el unknown
- 2016-08-23 SM SM201600284T patent/SMT201600284B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2588059T3 (es) | 2016-10-28 |
| EP2699545B1 (fr) | 2016-05-25 |
| JP5986625B2 (ja) | 2016-09-06 |
| PL2699545T3 (pl) | 2017-01-31 |
| EP2699545A1 (fr) | 2014-02-26 |
| CN103619814A (zh) | 2014-03-05 |
| WO2012143660A1 (fr) | 2012-10-26 |
| HUE030432T2 (en) | 2017-05-29 |
| DK2699545T3 (en) | 2016-08-29 |
| US9303019B2 (en) | 2016-04-05 |
| CN103619814B (zh) | 2016-01-20 |
| SI2699545T1 (sl) | 2016-12-30 |
| HRP20161024T1 (hr) | 2016-11-04 |
| CA2833339C (fr) | 2020-09-15 |
| CA2833339A1 (fr) | 2012-10-26 |
| PT2699545T (pt) | 2016-08-30 |
| US20140045910A1 (en) | 2014-02-13 |
| RS55061B1 (sr) | 2016-12-30 |
| LT2699545T (lt) | 2016-09-26 |
| SMT201600284B (it) | 2016-11-10 |
| JP2014514316A (ja) | 2014-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123476T1 (el) | Τροποποιητες πυρηνικης μεταφορας και χρησεις αυτων | |
| CY1122730T1 (el) | 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων | |
| CY1124729T1 (el) | Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου | |
| CY1124436T1 (el) | Δικυκλικες ετεροκυκλικες ενωσεις και χρησεις αυτων στη θεραπεια | |
| CY1124928T1 (el) | Αναστολεις πυραζολυλο κινοξαλινο κινασης | |
| CY1124298T1 (el) | Φενφλουραμινη για χρηση στην θεραπευτικη αντιμετωπιση του συνδρομου dravet | |
| CY1122292T1 (el) | Ενωσεις και μεθοδοι για αντιϊικη αγωγη | |
| CY1121849T1 (el) | Μεθοδοι και συνθεσεις για τη θεραπεια του καρκινου | |
| CY1120318T1 (el) | Υποκατεστημενες βενζυλινδαζολες για χρηση ως αναστολεις κινασης bub1 στη θεραπευτικη αντιμετωπιση υπερπολλαπλασιαστικων ασθενειων | |
| CY1119490T1 (el) | Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων | |
| CL2015000829A1 (es) | Inhibidores de histona desmetilasas | |
| CY1119798T1 (el) | Μορφη iv υδροχλωρικης ιβαμπραδινης | |
| EA201591363A1 (ru) | Аналоги тиадиазола и способы лечения состояний, связанных с дефицитом smn | |
| CL2013003313A1 (es) | Compuestos derivados de 2,4-diaminoquinazolinas, sales o solvatos farmacéuticamente aceptables; composición farmacéutica que los comprende; y uso en el tratamiento de un trastorno en el que interviene la modulación de tlr7 y/o tlr8. | |
| CY1112813T1 (el) | 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων | |
| CY1124331T1 (el) | Αυξημενη βιοδιαθεσιμοτητα δραστικης ουσιας σε θεραπεια ναλτρεξονης | |
| NI201300112A (es) | Composición que comprende aflibercept, ácido folínico, 5 - fluorouracilo (5 - fu) e irinotecano ( folfiri). | |
| CY1121554T1 (el) | Παραγωγο πυρανοχρωμενυλ-φαινολης, και φαρμακευτικη συνθεση για αγωγη μεταβολικου συνδρομου ή φλεγμονωδους παθησης | |
| UY34775A (es) | Uso de laquinimod en alta dosis para el tratamiento de la esclerosis múltiple | |
| CY1121628T1 (el) | 7-βενζυλ-4-(2-μεθυλοβενζυλ)-2,4,6,7,8,9-εξαϋδροϊμιδαζο[1,2-α]πυριδο[3,4-ε]πυριμιδιν-5(1η)-ονη, αλατα αυτης και μεθοδοι χρησης | |
| CR20150211A (es) | Compuestos diméricos | |
| UA114417C2 (uk) | Інгібітори iap | |
| CY1120133T1 (el) | Πυριδαζινονες ως αναστολεις ενζυμου daao | |
| EA201691566A1 (ru) | Применение производных пиридазина для предупреждения или лечения атаксического синдрома | |
| UY34543A (es) | Derivados de sulfonilaminopirrolidinona, su preparación y aplicación terapéutica. |